RUNX2 and breast carcinoma: Notably, bone-colonizing breast cancer cells further upregulate osteogenic transcription factors like Runx2, promote the release of bone growth factors and cytokines, accelerate tumor growth, and form a vicious cycle (Song and Wei Cli, 2022).